Stock Track | Core Scientific Plunges 6.01% in Pre-Market on Wider-Than-Expected Q1 Loss and Insider Selling

Stock Track05-07

Core Scientific, Inc. (CORZ) stock plummeted 6.01% in pre-market trading on Thursday, extending losses from the previous session.

The sharp decline followed the company's release of first-quarter fiscal 2026 financial results, which showed a wider-than-expected loss. Core Scientific reported a net loss of $347.2 million, or $1.06 per diluted share, significantly missing the FactSet consensus estimate of a $0.06 loss. The results included $266.5 million in non-cash impairment charges, representing a sharp swing from profitability in the year-ago period.

Additional negative pressure came from regulatory filings showing insider stock sales by the company's Chief Legal Officer just days before the earnings release, which may have contributed to the bearish sentiment among investors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment